ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons

Cited by (624)

Items 101–200 of 624

1. Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
   Anna Andrea Lauer, Heike S. Grimm, Birgit Apel, Nataliya Golobrodska, Lara Kruse, Elina Ratanski, Noemi Schulten, Laura Schwarze, Thomas Slawik, Saskia Sperlich et al. · 2022 · Publications of the UdS (Saarland University)
2. Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease
   Olav M. Andersen, Ina‐Maria Rudolph, Thomas E. Willnow · 2016 · Acta Neuropathologica
3. Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins
   Hani Goodarzi, Steven Zhang, Colin G. Buss, Lisa Fish, Saeed Tavazoie, Sohail F. Tavazoie · 2014 · Nature
4. Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10
   Hamida Hammad, Matthias A. Vanderkerken, Philippe Pouliot, Kim Deswarte, Wendy Toussaint, Karl Vergote, Lana Vandersarren, Sophie Janssens, Ioanna Ramou, Savvas N. Savvides et al. · 2017 · Nature Immunology
5. Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease
   Hassan Bukhari, Annika Glotzbach, Katharina Kolbe, Gregor Leonhardt, Christina Loosse, Thorsten Müller · 2017 · Progress in neurobiology
6. Huntingtin and the Synapse
   Barron, Jessica C., Hurley, Emily P., Parsons, Matthew P. · 2021 · Frontiers in Cellular Neuroscience
7. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease
   P. Agostinho, A. Pliássova, C. Oliveira, R. Cunha · 2015 · Journal of Alzheimer's Disease
8. Diverse functions of the prion protein – Does proteolytic processing hold the key?
   Luise Linsenmeier, Hermann C. Altmeppen, Sebastian Wetzel, Behnam Mohammadi, Paul Säftig, Markus Glatzel · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
9. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer’s Disease Mouse Models
   Gloria Biella, Federica Fusco, Emanuele Nardo, Ottavia Bernocchi, Alessio Vittorio Colombo, Stefan F. Lichtenthaler, Gianluigi Forloni, Diego Albani · 2016 · Journal of Alzheimer s Disease
10. Alzheimer’s disease: as it was in the beginning
    Stanislav O. Kozlov, Alexey М. Afonin, Igor Evsyukov, А. Б. Бондаренко · 2017 · Reviews in the Neurosciences
11. Calmodulin Binding Proteins and Alzheimer’s Disease
    Danton H. O’Day, Kristeen Eshak, Michael A. Myre · 2015 · Journal of Alzheimer s Disease
12. Translational Repression of the Disintegrin and Metalloprotease ADAM10 by a Stable G-quadruplex Secondary Structure in Its 5′-Untranslated Region
    Sven Lammich, Frits Kamp, Judith Wagner, Brigitte Nuscher, Sonja Zilow, Ann‐Katrin Ludwig, Michael Willem, Christian Haass · 2011 · Journal of Biological Chemistry
13. Synaptic dysfunction in early phases of Alzheimer's Disease
    Silvia Pelucchi, Fabrizio Gardoni, Mónica Di Luca, Elena E. Marcello · 2022 · Handbook of clinical neurology
14. ADAM10 and BACE1 are localized to synaptic vesicles
    Jolanta L. Lundgren, Saheeb Ahmed, Sophia Schedin‐Weiss, Gunnar K. Gouras, Bengt G. Winblad, Lars O. Tjernberg, Susanne Frykman · 2015 · Journal of Neurochemistry
15. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
    Patrícia Regina Manzine, Miren Ettcheto, Amanda C. Cano, Oriol Busquets, Elena E. Marcello, Silvia Pelucchi, Mónica Di Luca, Kristina Endres, Jordi Olloquequi, Antoni Camins et al. · 2019 · Biomedicine & Pharmacotherapy
16. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10
    Regina Augustin, Kristina Endres, Sven Reinhardt, Peer‐Hendrik Kuhn, Stefan F. Lichtenthaler, Jens Hansen, Wolfgang Wurst, Dietrich Trümbach · 2012 · BMC Medical Genetics
17. Human stem cell–derived monocytes and microglia‐like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2
    Christel Claes, Johanna Van Den Daele, Ruben Boon, Sarah Schouteden, Alessio Vittorio Colombo, Laura Sebastián Monasor, Mark W. E. J. Fiers, Laura Ordovás, Fatemeharefeh Nami, Bernd Bohrmann et al. · 2018 · Alzheimer s & Dementia
18. Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP
    Laura García-González, Dominika Pilat, K. Baranger, S. Rivera · 2019 · Frontiers in Aging Neuroscience
19. EpCAM proteolysis: new fragments with distinct functions?
    Ulrike Schnell, Jeroen Kuipers, Ben N. G. Giepmans · 2013 · Bioscience Reports
20. Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo
    Jonathan R. Fisher, Clare E. Wallace, Danielle L. Tripoli, Yvette I. Sheline, John R. Cirrito · 2016 · Molecular Neurodegeneration
21. Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice
    Wang, Jun, Sun, Bin-Lu, Xiang, Yang, Tian, Ding-Yuan, Zhu, Chi, Li, Wei-Wei, Liu, Yu-Hui, Bu, Xian-Le, Shen, Lin-Lin, Jin, Wang-Sheng et al. · 2020 · Translational Psychiatry
22. Regulation of alpha-secretase ADAM10 expression and activity
    Kristina Endres, Falk Fahrenholz · 2011 · Experimental Brain Research
23. Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
    Grant Pfundstein, Alexander G. Nikonenko, Vladimir Sytnyk · 2022 · Frontiers in Cell and Developmental Biology
24. Alzheimer culprits: Cellular crossroads and interplay
    Sylvie Claeysen, Maud Cochet, Romain Donneger, Aline Dumuis, Joël Bockaert, Patrizia Giannoni · 2012 · Cellular Signalling
25. SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation
    Javier Rueda‐Carrasco, María Jesús Martín‐Bermejo, Guadalupe Pereyra, María Inés Mateo, Aldo Borroto, Frederic Brosseron, Markus P. Kummer, Stephanie Schwartz, José P. López‐Atalaya, Balbino Alarcón et al. · 2021 · EMBO Reports
26. Identification and biology of α‐secretase
    Valérie Vingtdeux, P. Marambaud · 2012 · Journal of Neurochemistry
27. Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease
    B. Tang · 2020 · Toxics
28. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
    Yunying Yang, Zhentao Zhang · 2020 · Frontiers in Aging Neuroscience
29. Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines
    Alessio Vittorio Colombo, Huanhuan Wang, Peer‐Hendrik Kuhn, Richard Page, Elisabeth Kremmer, Peter J. Dempsey, Howard C. Crawford, Stefan F. Lichtenthaler · 2012 · Neurobiology of Disease
30. Trafficking in Alzheimer’s Disease: Modulation of APP Transport and Processing by the Transmembrane Proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin
    Simone Eggert, Carolin Thomas, Stefan Kins, Guido Hermey · 2017 · Molecular Neurobiology
31. Novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers
    Daniela Kaden, Anja Harmeier, Christoph Weise, Lisa Marie Munter, Veit Althoff, Benjamin R. Rost, Peter Werner Hildebrand, Dietmar Schmitz, Michael Schaefer, Rudi Lurz et al. · 2012 · EMBO Molecular Medicine
32. Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site
    Caroline Schönherr, Jessica Bien, Simone Isbert, Rielana Wichert, Johannes Prox, Hermann C. Altmeppen, Sathish Kumar, Jochen Walter, Stefan F. Lichtenthaler, Sascha Weggen et al. · 2016 · Molecular Neurodegeneration
33. Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
    Tong Wu, Lin Ding, Ya‐Qian Cheng, Senze Jiang, Muhammad Waheed Riaz, Nina Fu, Chenhao Mou, Menglu Ye, Ying Zheng · 2022 · Aging and Disease
34. Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
    Benedikt Kretner, Johannes Trambauer, Akio Fukumori, Janina Mielke, Peer‐Hendrik Kuhn, Elisabeth Kremmer, Armin Giese, Stefan F. Lichtenthaler, Christian Haass, Thomas Arzberger et al. · 2016 · EMBO Molecular Medicine
35. Alzheimer's Disease‐Associated Ubiquilin‐1 Regulates Presenilin‐1 Accumulation and Aggresome Formation
    Jayashree Viswanathan, Annakaisa Haapasalo, Claudia Böttcher, Riitta A. Miettinen, Kaisa M. A. Kurkinen, Alice Lu, Anne Thomas, Christa J. Maynard, Donna Romano, Bradley T. Hyman et al. · 2010 · Traffic
36. Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
    Riqiang Yan, Qingyuan Fan, John Zhou, Robert J. Vassar · 2016 · Neuroscience & Biobehavioral Reviews
37. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer’s disease
    Huiqin Li, Siu‐Po Ip, Qiuju Yuan, Guo‐qing Zheng, Karl Wah Keung Tsim, Tina Ting-Xia Dong, Ge Lin, Yifan Han, Yue Liu, Yan‐Fang Xian et al. · 2019 · Brain Behavior and Immunity
38. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome
    Emanuela Pasciuto, Tariq Ahmed, Tina Wahle, Fabrizio Gardoni, Laura D’Andrea, Laura Pacini, Sébastien Jacquemont, Flora Tassone, Detlef Balschun, Carlos G. Dotti et al. · 2015 · Neuron
39. BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System
    Niklas Mattsson, Lawrence Rajendran, Henrik Zetterberg, Mikael K. Gustavsson, Ulf Andréasson, Maria Olsson, Gunnar Brinkmalm, Johan Lundkvist, Laura H. Jacobson, Ludovic Perrot et al. · 2012 · PLoS ONE
40. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma
    Sarah Abdullahi, Melanie Jäkel, Sabine J. Behrend et al. · 2018 · Journal of Virology
41. The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer’s Disease
    Meng Qian, Xiaoqiang Shen, Huanhuan Wang · 2015 · Cellular and Molecular Neurobiology
42. ADAM9 Inhibition Increases Membrane Activity of ADAM10 and Controls α-Secretase Processing of Amyloid Precursor Protein
    Marcia L. Moss, Gary Powell, Miles Aaron Miller, Lori L. Edwards, Bin Qi, Qing‐Xiang Amy Sang, Bart De Strooper, Ina C. Tesseur, Stefan F. Lichtenthaler, Mara Taverna et al. · 2011 · Journal of Biological Chemistry
43. SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylation
    Claudia Saraceno, Elena E. Marcello, Daniele Di Marino, Barbara Borroni, Sylvie Claeysen, Julie Perroy, Alessandro Padovani, Anna Luna Tramontano, Fabrizio Gardoni, Mónica Di Luca · 2014 · Cell Death and Disease
44. Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease
    Kévin Baranger, Patrizia Giannoni, Stéphane D. Girard, Sarah Girot, Florence Gaven, Delphine Stephan, Martine Migliorati, Michel Khrestchatisky, Joël Bockaert, E Marchetti et al. · 2017 · Neuropharmacology
45. Activation of NMDA Receptors Upregulates A Disintegrin and Metalloproteinase 10 via a Wnt/MAPK Signaling Pathway
    Xian-Zi Wan, Bei Li, Yi-Chen Li, Xiangling Yang, Wei Zhang, Ling Zhong, Shao-Jun Tang · 2012 · Journal of Neuroscience
46. Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease
    Nady Braidy, Musthafa Mohamed Essa, Anne Poljak, Selvaraju Subash, Samir Al‐Adawi, Thamilarasan Manivasagm, Arokiasamy Justin Thenmozhi, Lezanne Ooi, Perminder Singh Sachdev, Gilles J. Guillemin · 2016 · Oncotarget · Retracted
47. 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice
    Divna Lazić, Abhay P. Sagare, Angeliki Maria Nikolakopoulou, John H. Griffin, Robert J. Vassar, Berislav V. Zloković · 2019 · The Journal of Experimental Medicine
48. Degradome of soluble ADAM10 and ADAM17 metalloproteases
    Franka Scharfenberg, Andreas O. Helbig, Martin Sammel, Julia Benzel, Uwe Schlomann, Florian Peters, Rielana Wichert, Maximilian Bettendorff, Dirk Schmidt‐Arras, Stefan Rose‐John et al. · 2019 · Cellular and Molecular Life Sciences
49. Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model
    Asmaa M. Elfiky, Asmaa Ahmed Mahmoud, Hala A. Elreedy · 2021 · Life Sciences
50. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications
    Zhongya Gu, Huấn Cao, Chengchao Zuo, Yaqi Huang, Jinfeng Miao, Yu Song, Yuyan Yang, Liudi Zhu, Furong Wang · 2022 · Neurobiology of Disease
51. Opposite effects of P2X7 and P2Y2nucleotide receptors on α-secretase-dependent APP processing in Neuro-2a cells
    Míriam León‐Otegui, Rosa Gómez‐Villafuertes, Juan Ignacio Díaz‐Hernandéz, Miguel Dı́az-Hernández, M. Teresa Miras‐Portugal, Javier Gualix · 2011 · FEBS Letters
52. Modeling Alzheimer’s disease: from past to future
    Claudia Saraceno, Stefano Musardo, Elena E. Marcello, Silvia Pelucchi, Mónica Di Luca · 2013 · Frontiers in Pharmacology
53. The Role of Cholesterol Metabolism in Alzheimer’s Disease
    Sun, Jia-Hao, Yu, Jin-Tai, Tan, Lan · 2015 · Molecular Neurobiology
54. ADAM10 Is the Major Sheddase Responsible for the Release of Membrane-associated Meprin A
    Christian Herzog, Randy S. Haun, Andreas Ludwig, Sudhir V. Shah, Gur P. Kaushal · 2014 · Journal of Biological Chemistry
55. ADAM10 as a Biomarker for Alzheimer’s Disease: A Study with Brazilian Elderly
    Patrícia Regina Manzine, Jessyka Maria de França Bram, Elizabeth Joan Barham · 2013 · Dementia and Geriatric Cognitive Disorders
56. Huperzine a alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice
    Ying Wang, Xi Can Tang, Haiyan Zhang · 2011 · Journal of Neuroscience Research
57. Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice.
    I. Tesseur, Anna A. Pimenova, Adrian C. Lo, M. Ciesielska, S. Lichtenthaler, J. D. De Maeyer, J. Schuurkes, R. D'Hooge, B. de Strooper · 2013 · Neurobiology of Aging
58. Cleavage of Signal Regulatory Protein α (SIRPα) Enhances Inflammatory Signaling
    James David Londino, Dexter L. Gulick, Jeffrey Scott Isenberg · 2015 · Journal of Biological Chemistry
59. ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer’s disease
    Elena E. Marcello, Barbara Borroni, Silvia Pelucchi, Fabrizio Gardoni, Mónica Di Luca · 2017 · Expert Opinion on Therapeutic Targets
60. ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
    Florent Letronne, Geoffroy O. Laumet, Anne‐Marie Ayral, Julien Chapuis, Florie Demiautte, Mathias Laga, Michel Erminio Vandenberghe, Nicolas Malmanche, Florence Leroux, Fanny Eysert et al. · 2016 · EBioMedicine
61. Physical and functional interaction between the α- and γ-secretases: A new model of regulated intramembrane proteolysis
    Allen C. Chen, Sumin Kim, Nina E. Shepardson, Sarvagna Patel, Soyon Youngae Hong, Dennis J. Selkoe · 2015 · The Journal of Cell Biology
62. Alternative Processing of the Amyloid Precursor Protein Family by Rhomboid Protease RHBDL4
    Sandra Paschkowsky, Mehdi Hamzé, Felix Oestereich, Lisa Marie Munter · 2016 · Journal of Biological Chemistry
63. Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium
    Livius V. d’Uscio, Tongrong He, Zvonimir S. Katušić · 2016 · Physiology
64. Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
    Juan Ramón Perea, Alberto Lleó, Daniel Andres Alcolea, Juan Fortea, Jesús Ávila, Marta Bolós · 2018 · Frontiers in Neuroscience
65. BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease
    Marta Del Campo, Jeroen J.M. Hoozemans, Lois-Lee Dekkers, Annemieke J.M. Rozemüller, Carsten Korth, Andreas Müller‐Schiffmann, Philip Scheltens, Marinus A. Blankenstein, Connie R. Jiménez, Robert Veerhuis et al. · 2014 · Neurobiology of Aging
66. Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production
    Rachel A. Rice, Nicole C. Berchtold, Carl W. Cotman, Kim N. Green · 2013 · Neurobiology of Aging
67. Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
    Kathryn M. Munro, Amelia Nash, Martina Pigoni, Stefan F. Lichtenthaler, Jenny Margaret Gunnersen · 2016 · Journal of Molecular Neuroscience
68. Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks
    Reinhardt, Sven, Stoye, Nicolai, Luderer, Mathias, Kiefer, Falk, Schmitt, Ulrich, Lieb, Klaus, Endres, Kristina · 2018 · Scientific Reports
69. Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials
    Krzysztof Drygalski, Eliza Fereniec, Krzysztof Koryciński, Andrzej Chomentowski, Aleksandra Kiełczewska, Cezary Odrzygóźdź, Beata Modzelewska · 2018 · Experimental Gerontology
70. The role of proteases in regulating Eph/ephrin signaling
    Lakmali Atapattu, Martin Lackmann, Peter W. Janes · 2014 · Cell Adhesion & Migration
71. Calmodulin Binding Proteins and Alzheimer’s Disease: Biomarkers, Regulatory Enzymes and Receptors That Are Regulated by Calmodulin
    Danton H. O’Day · 2020 · International Journal of Molecular Sciences
72. Structural basis for membrane-proximal proteolysis of substrates by ADAM10
    Colin H. Lipper, Emily D. Egan, Khal-Hentz Gabriel, Stephen C. Blacklow · 2023 · Cell
73. ER-stress in Alzheimer's disease: turning the scale?
    Kristina Endres, Sven Reinhardt · 2013 · Europe PMC (PubMed Central)
74. Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin
    Johannes Prox, Andrea Rittger, P. Saftig · 2011 · Experimental Brain Research
75. DISC1 regulates trafficking and processing of APP and Aβ generation
    Neelam Shahani, Saurav Seshadri, Hanna Jaaro-Peled, K Ishizuka, Yuki Hirota-Tsuyada, Qi Wang, Minori Koga, Thomas W. Sedlak, Carsten Korth, Nicholas J. Brandon et al. · 2014 · Molecular Psychiatry
76. Carnosic acid suppresses the production of amyloid-β 1–42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells
    Pengfei Meng, Hidemi Yoshida, Tomoh Matsumiya et al. · 2012 · Neuroscience Research
77. Neural stem/progenitor cells in Alzheimer's disease.
    Gizem Tincer, Violeta Mashkaryan, Prabesh Bhattarai, Çağhan Kızıl · 2016 · Europe PMC (PubMed Central)
78. Therapeutic approaches in the improvement of cognitive performance in Down syndrome
    de la Torre, Rafael, Dierssen, Mara · 2012 · Progress in Brain Research
79. Dietary lipids and their oxidized products in Alzheimer's disease
    Laura Corsinovi, Fiorella Biasi, Giuseppe Poli, Gabriella Leonarduzzi, Giancarlo Isaia · 2011 · Molecular Nutrition & Food Research
80. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    K. Baranger, S. Rivera, F. Liechti, D. Grandgirard, J. Bigas, Jesus Seco, T. Tarragó, S. Leib, M. Khrestchatisky · 2014 · Progress in Brain Research
81. The Alzheimer’s Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides
    Gabriele Siegel, Hermeto Gerber, Philipp Koch, Bruestle Oliver, Patrick C. Fraering, Lawrence Rajendran · 2017 · Cell Reports
82. Redox signaling and metabolism in Alzheimer's disease
    Mariana Inés Holubiec, Manuela Gellert, Eva-Maria Hanschmann · 2022 · Frontiers in Aging Neuroscience
83. Shedding of APP limits its synaptogenic activity and cell adhesion properties
    Stahl, Ronny, Schilling, Sandra, Soba, Peter, Rupp, Carsten, Hartmann, Tobias, Wagner, Katja, Merdes, Gunter, Eggert, Simone, Kins, Stefan · 2014 · Frontiers in Cellular Neuroscience
84. Alzheimer disease: modeling an Aβ-centered biological network
    Dominique Campion, Cyril P. Pottier, Gaël Nicolas, Kilan Le Guennec, Anne Rovelet‐Lecrux · 2016 · Molecular Psychiatry
85. MT5-MMP Promotes Alzheimer’s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro
    K. Baranger, Amandine Bonnet, Stéphane D. Girard, Jean-Michel Paumier, Laura García-González, Wejdane Elmanaa, A. Bernard, E. Charrat, D. Stephan, Charlotte Bauer et al. · 2017 · Frontiers in Molecular Neuroscience
86. Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells
    Hidemi Yoshida, Pengfei Meng, Tomoh Matsumiya, Kunikazu Tanji, Ryo Hayakari, Fei Xing, Liang You Wang, Kazushi Tsuruga, Hiroshi Tanaka, Junsei Mimura et al. · 2013 · Neuroscience Research
87. Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling
    Anna A. Pimenova, Amantha Thathiah, Bart De Strooper, Ina C. Tesseur · 2014 · PLoS ONE
88. Determination of the Proteolytic Cleavage Sites of the Amyloid Precursor-Like Protein 2 by the Proteases ADAM10, BACE1 and γ-Secretase
    Sebastian Hogl, Peer‐Hendrik Kuhn, Alessio Vittorio Colombo, Stefan F. Lichtenthaler · 2011 · PLoS ONE
89. Depression in Alzheimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?
    Richard J. Elsworthy, Sarah Aldred · 2019 · Journal of Alzheimer s Disease
90. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway
    Kotaro Furusawa, Toshiyuki Takasugi, Yung‐Wen Chiu, Yukiko Hori, Taisuke Tomita, Mitsunori Fukuda, Shin‐ichi Hisanaga · 2019 · Journal of Biological Chemistry
91. New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10)
    David Rosenbaum, Paul Säftig · 2023 · FEBS Journal
92. The relationship between cholesterol level and Alzheimer’s disease-associated APP proteolysis/Aβ metabolism
    Chao-Qun Wang, Yikai Shou, Jie Pan, Yue Du, Cui-Qing Liu, Huanhuan Wang · 2018 · Nutritional neuroscience
93. Levels of ADAM10 are reduced in Alzheimer’s disease CSF
    Aitana Sogorb‐Esteve, María‐Salud García‐Ayllón, Johan Gobom, Jordi Alom, Henrik Zetterberg, Kaj Blennow, Javier Sáez‐Valero · 2018 · Journal of Neuroinflammation
94. Brothers in Arms: ProBDNF/BDNF and sAPPα/Aβ-Signaling and Their Common Interplay with ADAM10, TrkB, p75NTR, Sortilin, and sorLA in the Progression of Alzheimer’s Disease
    Eggert, Simone, Kins, Stefan, Endres, Kristina, Brigadski, Tanja · 2022 · Biological Chemistry
95. The trans-Golgi network is a major site for α-secretase processing of amyloid precursor protein in primary neurons
    Jing Zhi Anson Tan, Paul A. Gleeson · 2018 · Journal of Biological Chemistry
96. Key Peptides and Proteins in Alzheimer’s Disease
    Botond Penke, Ferenc Bogár, Gábor Paragi, János Gera, Lívia Fülöp · 2019 · Current Protein and Peptide Science
97. The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
    Stephan A. Müller, Merav D. Shmueli, Xiao Ming Feng, Johanna Tüshaus, Neele Schumacher, Ryan Clark, Brad E. Smith, An Chi, Stefan Rose‐John, Matthew E Kennedy et al. · 2023 · Molecular Neurodegeneration
98. Alzheimer's disease genes and autophagy
    Seung‐Yong Yoon, Dong‐Hou Kim · 2016 · Brain Research
99. NrCAM is a marker for substrate‐selective activation of ADAM10 in Alzheimer's disease
    Tobias Brummer, Stephan A. Müller, Francisco J. Pan-Montojo, Fumiaki Yoshida, Andreas Fellgiebel, Taisuke Tomita, Kristina Endres, Stefan F. Lichtenthaler · 2019 · EMBO Molecular Medicine
100. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease
     Gunnar Brinkmalm, Ann Brinkmalm, Philippe Bourgeois, Rita Persson, Oskar Hansson, Erik Portelius, Marc H. Mercken, Ulf Andréasson, Stéphane Parent, Francesco Lipari et al. · 2013 · Brain Research